Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Sefton

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1993
Successful treatment of concomitant pulmonary nocardiosis and aspergillosis in an immunocompromised renal patientR I Holt, J T Kwan, A M Sefton, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1997
Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus sppJ D Williams, J P Maskell, A C Whiley, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1989
Comparative pharmacokinetic study between lenampicillin, bacampicillin and amoxycillinZ M Sum, A M Sefton, A P Jepson, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1996
Comparative in-vitro activity of CP-99219, a new quinolone, against respiratory pathogensA M Sefton, J P Maskell, A C Seymour, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1997
The in-vitro activity of trovafloxacin, a new fluoroquinolone, against Gram-positive bacteriaA M Sefton, J P Maskell, A M Rafay, et al.
Infection|January 1, 1988
Comparative in-vitro activity of erythromycin, vancomycin and pristinamycinJ P Maskell, A M Sefton, J Yong, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1988
Comparative in vitro activity of A-56268A M Sefton, J P Maskell, F J Yong, et al.
The Journal of Antimicrobial Chemotherapy|May 28, 2004
Post-exposure prophylaxis of systemic anthrax in mice and treatment with fluoroquinolonesJ Steward, M S Lever, A J H Simpson, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1990
Comparative efficacy and tolerance of erythromycin and josamycin in the prevention of bacteraemia following dental extractionA M Sefton, J P Maskell, C Kerawala, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1990
Predominance of resistant oral streptococci in saliva and the effect of a single course of josamycin or erythromycinJ P Maskell, A M Sefton, H Cannell, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1993
Successful treatment of concomitant pulmonary nocardiosis and aspergillosis in an immunocompromised renal patientR I Holt, J T Kwan, A M Sefton, et al.
The Journal of Antimicrobial Chemotherapy|May 1, 1997
Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus sppJ D Williams, J P Maskell, A C Whiley, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1989
Comparative pharmacokinetic study between lenampicillin, bacampicillin and amoxycillinZ M Sum, A M Sefton, A P Jepson, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1996
Comparative in-vitro activity of CP-99219, a new quinolone, against respiratory pathogensA M Sefton, J P Maskell, A C Seymour, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1997
The in-vitro activity of trovafloxacin, a new fluoroquinolone, against Gram-positive bacteriaA M Sefton, J P Maskell, A M Rafay, et al.
Infection|January 1, 1988
Comparative in-vitro activity of erythromycin, vancomycin and pristinamycinJ P Maskell, A M Sefton, J Yong, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|December 1, 1988
Comparative in vitro activity of A-56268A M Sefton, J P Maskell, F J Yong, et al.
The Journal of Antimicrobial Chemotherapy|May 28, 2004
Post-exposure prophylaxis of systemic anthrax in mice and treatment with fluoroquinolonesJ Steward, M S Lever, A J H Simpson, et al.
The Journal of Antimicrobial Chemotherapy|June 1, 1990
Comparative efficacy and tolerance of erythromycin and josamycin in the prevention of bacteraemia following dental extractionA M Sefton, J P Maskell, C Kerawala, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1990
Predominance of resistant oral streptococci in saliva and the effect of a single course of josamycin or erythromycinJ P Maskell, A M Sefton, H Cannell, et al.
Pageof 3